Expectations for Phase-Appropriate Drug Substance and Drug Product Specifications for Early-Stage Protein Therapeutics. [electronic resource]
Producer: 20200527Description: 1442-1452 p. digitalISSN:- 1520-6017
- Antibodies, Monoclonal -- chemistry
- Clinical Trials, Phase I as Topic -- standards
- Drug Development -- standards
- Drug Industry -- standards
- Humans
- Immunoconjugates -- chemistry
- Quality Control
- Risk Assessment
- Surveys and Questionnaires -- statistics & numerical data
- Technology, Pharmaceutical -- standards
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.